Search Results
Jan 12, 2026, 00:22 ET ADI Foundation and Finstreet Partner with BlockBooster to Lead Ecosystem Development for Regulated Tokenized Products
tokenization and listing of private credit, private equity and technology-related assets suitable for institutional investors; and(iii) Ecosystem development, including potential collaboration on investments, supporting infrastructure, asset onboarding and coordinated go-to-market
More news about: ADI Foundation
Jan 11, 2026, 15:00 ET REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program
ASCENT® pivotal trials of sura-vec using subretinal delivery in Q4 2026.REGENXBIO will initiate a two-part sham injection-controlled Phase IIb/III trial of sura-vec for DR using suprachoroidal delivery. The Company will receive a $100 million milestone payment from AbbVie upon first patient dosed,
More news about: REGENXBIO Inc.
Jan 11, 2026, 12:00 ET IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
(ii) the timing and content of clinical program updates, regulatory updates and clinical trial data readouts, including those at medical conferences; (iii) the potential and timing for an accelerated approval filing for darovasertib; (iv) the timing of darovasertib in three Phase 3 registrational trials
More news about: IDEAYA Biosciences, Inc.
Jan 10, 2026, 13:10 ET Robbins Geller Rudman & Dowd LLP Announces that StubHub Holdings, Inc. (STUB) Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit
timing of payments to vendors; (ii) those changes had a significant adverse impact on free cash flow, including trailing 12 months free cash flow; and (iii) as a result, StubHub's free cash flow reports were materially misleading. The quarterly report allegedly revealed that this year-over-year
More news about: Robbins Geller Rudman & Dowd LLP
Jan 10, 2026, 10:00 ET RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer
Ann Oncol. 2014;25(1):107-116. doi:10.1093/annonc/mdt5239 Santini A, Lenz HJ, Eng C, et al. Extended RAS analysis of the phase III EPIC trial: irinotecan plus cetuximab versus irinotecan as second-line treatment for patients with metastatic colorectal cancer. Oncologist. 2021;26(2):e261-e269.
More news about: Johnson & Johnson
Jan 10, 2026, 08:39 ET Shrub Oak International School's Music Program Demonstrates the Power of Individualized Learning for Autistic Students
support.Shrub Oak International School is accredited by:The National Independent Private Schools Association (NIPSA), Level III Therapeutic Certification, Academic Accreditation, with an Autism Endorsement;The Middle States Association Commission on Elementary and Secondary
More news about: Shrub Oak International School
Jan 09, 2026, 22:16 ET Jayud Global Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Jayud Global Logistics Limited - JYD
(ii) insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (iii) the Company's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity elevating the stock price;
More news about: ClaimsFiler
Jan 09, 2026, 22:11 ET Coupang Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Coupang, Inc. - CPNG
information for nearly six months without being detected; (ii) this subjected the Company to a materially heightened risk of regulatory and legal scrutiny; (iii) when defendants became aware that the Company had been subjected to this data breach, they did not report it in a current report filing in compliance
More news about: ClaimsFiler
Jan 09, 2026, 10:17 ET SciBase publishes information document regarding rights issue
or anyone on whose behalf the investor acts, directly or indirectly, would have a direct or indirect influence on the management of the Company, and iii) the investor, someone in its ownership structure or someone on whose behalf the investor is acting, would through the investment have a direct or indirect
More news about: SciBase
Jan 09, 2026, 09:00 ET Investors who lost money on Skye Bioscience, Inc.(SKYE) should contact Levi & Korsinsky about pending Class Action - SKYE
effective than defendants had led investors to believe; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.WHAT'S NEXT? If you suffered a loss
More news about: Levi & Korsinsky, LLP
Jan 09, 2026, 09:00 ET SLM Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 17, 2026 to Discuss Your Rights - SLM
loss mitigation and/or loan modification programs, as well as the overall stability of the Company's private education loan delinquency rates; and (iii) as a result, defendants' public statements made a materially false and misleading impression regarding SLM's business, operations, and prospects at
More news about: Levi & Korsinsky, LLP
Jan 09, 2026, 09:00 ET DeFi Technologies Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - DEFT
treasury companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (iii) as a result of the foregoing issues, the Company was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (iv) accordingly,
More news about: Levi & Korsinsky, LLP
Jan 09, 2026, 09:00 ET Firefly Aerospace Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 12, 2026 to Discuss Your Rights - FLY
for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'
More news about: Levi & Korsinsky, LLP
Jan 09, 2026, 08:30 ET Bitmine Appoints Chief Financial Officer and Chief Operating Officer
Bitmine is supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, and Galaxy Digital to support Bitmine's goal of acquiring 5% of ETH: The alchemy of 5%LAS
More news about: BitMine Immersion Technologies, Inc.
Jan 09, 2026, 07:45 ET SciBase announces outcome of the offer to repurchase outstanding warrants of series TO 2
or anyone on whose behalf the investor acts, directly or indirectly, would have a direct or indirect influence on the management of the Company, and iii) the investor, someone in its ownership structure or someone on whose behalf the investor is acting, would through the investment have a direct or indirect
More news about: SciBase
Jan 09, 2026, 06:15 ET Haemonetics Acquires Vivasure Medical Limited
objectives of management for the operation of Haemonetics, (ii) the anticipated benefits to Haemonetics arising from the completion of the acquisition, (iii) the impact of the acquisition on Haemonetics' business strategy and future business and operational performance, and (iv) the assumptions underlying
More news about: Haemonetics Corporation
Jan 08, 2026, 20:37 ET Hisense Luncurkan 116UXS and XR10, RGB MiniLED Menuju Era Baru di CES 2026
dan solusi TI pintar. Menurut Omdia, volume penjualan TV Hisense ukuran 100 inci dan lebih berada di peringkat No.1 dunia (periode 2023-Triwulan III-2025). Hisense merupakan pelopor RGB MiniLED yang terus menghadirkan inovasi generasi baru. Sebagai sponsor resmi FIFA Club World Cup 2026™, Hisense berkomitmen
More news about: Hisense
Jan 08, 2026, 19:38 ET Goertek Unveils Comprehensive XR Portfolio at CES 2026, Highlighting Full-Scene AI Glasses and Advanced Optical Solutions
extended sessions of media consumption, light productivity tasks, and casual gaming, charting a clear path forward for mainstream MR adoption.III. From AR Full-Color Polymer Waveguides to Electrically Tunable Liquid Crystal Lenses: Defining the Next Frontier in XR OpticsAt CES, Goertek's
More news about: Goertek
Jan 08, 2026, 19:00 ET MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche
YL201 is currently under investigation in multinational clinical trials for a variety of advanced solid tumors. In China, it has advanced into two Phase III registrational trials for small cell lung cancer (SCLC) and nasopharyngeal carcinoma (NPC). Preliminary clinical data have demonstrated promising objective
More news about: MediLink Therapeutics
Jan 08, 2026, 18:14 ET ARDT INVESTOR ALERT: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Ardent Health Class Action Lawsuit
allowed Ardent Health to report higher amounts of accounts receivable during the Class Period, and delay recognizing losses on uncollectable accounts; (iii) consequently, Ardent Health's reported financial position was materially false and misleading; (iv) Ardent Health did not maintain professional malpractice
More news about: Robbins Geller Rudman & Dowd LLP
Jan 08, 2026, 16:15 ET Perimeter Medical Imaging AI Enters Systemwide Agreement with Intermountain Health
material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include,
More news about: Perimeter Medical Imaging AI Inc.
Jan 08, 2026, 15:37 ET CORUS ENTERTAINMENT MAILS AND FILES SPECIAL MEETING MATERIALS IN CONNECTION WITH PROPOSED RECAPITALIZATION TRANSACTION
Senior Notes will be settled in exchange for: (i) cash equal to the accrued and unpaid interest in respect of the Senior Notes; (ii) NewCo Shares; and (iii) $250 million principal amount of new second lien senior secured notes issued by Corus with a 6-year maturity date in an equal aggregate principal amount.
More news about: Corus Entertainment Inc (IR Group)
Jan 08, 2026, 13:13 ET TASTE OF THE NFL BRINGS SUPER BOWL LX'S ULTIMATE CULINARY EXPERIENCE TO SAN FRANCISCO TO RALLY SUPPORT TO END STUDENT HUNGER
vintages.PepsiCo brings additional culinary firepower with Chef Steven Dominguez, Associate Research Chef and Culinary Lead, and Chef Wiley E. Bates III, PepsiCo Culinary Senior Principal Scientist, alongside celebrated talents including Chef Eric Adjepong – the Ghanaian-American culinary trailblazer
More news about: GENYOUth
Jan 08, 2026, 12:49 ET Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights
TreeHouse Foods, Inc. (NYSE: THS)'s sale to Industrial F&B Investments III Inc. for $22.50 in cash per share plus a contingent value right. If you are a TreeHouse shareholder,
More news about: Halper Sadeh LLP
Jan 08, 2026, 12:30 ET MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Freeport-McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
(ii) the lack of proper safety precautions constituted a heightened risk that could foreseeably lead to the death of Freeport-McMoRan's workers; and (iii) this constituted an undisclosed heightened risk of regulatory, litigation, and reputational risk.The Freeport-McMoRan class action lawsuit
More news about: Robbins Geller Rudman & Dowd LLP